Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3704193017 | Lymphoproliferative disorder caused by methotrexate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3704194011 | Lymphoproliferative disorder caused by methotrexate (disorder) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3704195012 | Methotrexate-associated lymphoproliferative disorder | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3704196013 | Rare immunodeficiency-associated lymphoproliferative disease with characteristics of lymphoid proliferation or lymphomas (large B-cell lymphoma, T-cell lymphoma, Hodgkin lymphoma, reactive lymphadenitis and a polymorphic post-transplant lymphoproliferative disorder) that develop in patients with different autoimmune diseases treated with methotrexate. Swelling is the predominant manifestation of the disease and regression after methotrexate withdrawal is observed in a significant proportion of patients. | en | Definition | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 4211001000052114 | lymfoproliferativ sjukdom orsakad av metotrexat | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lymphoproliferative disorder caused by methotrexate | Is a | Drug-induced immunodeficiency | true | Inferred relationship | Some | ||
| Lymphoproliferative disorder caused by methotrexate | Causative agent | Methotrexate (substance) | true | Inferred relationship | Some | 1 | |
| Lymphoproliferative disorder caused by methotrexate | Associated morphology | Lymphoproliferative disorder (morphologic abnormality) | true | Inferred relationship | Some | 1 | |
| Lymphoproliferative disorder caused by methotrexate | Is a | Lymphoproliferative disorder | true | Inferred relationship | Some | ||
| Lymphoproliferative disorder caused by methotrexate | Finding site | Structure of immune system (body structure) | true | Inferred relationship | Some | 1 | |
| Lymphoproliferative disorder caused by methotrexate | Pathological process (attribute) | Abnormal immune process (qualifier value) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR